Patent · US Expired

Ion exchange tumor targeting (IETT)

US6569841B1 · kind B1 · utility

3Cited by

0References

21Claims

0Family size

Assignee

MAP Medical Technologies OY · FI

Inventor

Anders Holmberg · Uppsala, SE

Key dates

Filing date	Oct 3, 2001
Grant date	May 27, 2003
Priority date	—
Expiry date	Oct 3, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound for local, i.e. intratumoral or intracavitary administration, for targeting tumors comprising dextran, the charge of which has been modified through covalent binding of charged groups, such as charged amino acids. The compound further comprises a functional group for treating or imaging the tumor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.